Golf: Woods says has completed treatment to deal with medications
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[NEW YORK] Tiger Woods, who was a no-show last week at the PGA tournament that benefits his foundation, said on social media on Monday that he had completed a programme to help him manage medications he used to deal with back pain.
"I recently completed an out of state private intensive programme. I will continue to tackle this going forward with my doctors, family and friends. I am so very thankful for all the support I've received," Woods said on Twitter.
Woods checked himself into a clinic after blaming an unexpected reaction to prescribed medications for an early-morning DUI arrest near his Jupiter Island home in Florida on May 29.
The former world number one golfer, who has had several surgeries to relieve lingering back pain, was booked but released several hours later by Palm Beach County police.
"I want the public to know that alcohol was not involved," said Woods, whose police report showed he had passed a breathalyser test.
"What happened was an unexpected reaction to prescribed medications. I didn't realise the mix of medications had affected me so strongly."
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
Fourteen-times major winner Woods, 41, has not played professionally since withdrawing from a tournament in Dubai in February.
A 79-time winner on the PGA Tour, he has competed in only 19 events on the PGA Tour since the end of 2013, recording one top-10 finish during that period. He won his last major title at the 2008 US Open.
REUTERS
Share with us your feedback on BT's products and services
TRENDING NOW
Mustafa Centre begins fit-out at JB’s Capital City Mall after 2-year delay
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report